Last Update Time:
20-Mar-2025 16:00:00
ISIN:
INE061F01013
Sector:
Healthcare
Symbol:
FORTIS
Fortis Healthcare Limited
₹626.05
₹16.20
(2.66%)
▲
Prev. Close
₹609.85
Open
₹618.00
Close
₹627.35
Range
₹594.75 - ₹657.35
High
₹630.95
Low
₹612.85
Ind. Close
₹0.00
VWAP
₹625.72
The current stock price of Fortis Healthcare Limited is ₹626.05, with a target price range between ₹594.75 and ₹657.35. The stock has experienced a price change of ₹16.20 (2.66%), reflecting recent market volatility.
Today's opening price was ₹618.00, while the previous close stood at ₹609.85.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Fortis Healthcare Limited Price Chart
Fortis Healthcare Limited Pre Open Market Overview: 20-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 618
- Previous Close Price: 609.85
- Change: 8.15%
- Total Traded Volume: 1,936
- Total Buy Quantity: 21,844
- Total Sell Quantity: 12,962
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 613.00 | 1.00 | 0.00 |
| 613.50 | 500.00 | 0.00 |
| 614.00 | 1.00 | 0.00 |
| 615.00 | 1.00 | 0.00 |
| 616.00 | 1.00 | 0.00 |
| 618.00 | 0.00 | 116.00 |
| 618.40 | 0.00 | 300.00 |
| 618.65 | 0.00 | 50.00 |
| 618.90 | 0.00 | 100.00 |
| 618.95 | 0.00 | 7.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 21844
Total Sell Quantity: 12962
Shareholding Patterns of Fortis Healthcare Limited
Key Trade Statistics of Fortis Healthcare Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 14.96 |
| Traded Value (₹ Cr.) | 93.63 |
| Total Market Cap (₹ Cr.) | 47,264.15 |
| Free Float Market Cap (₹ Cr.) | 32,533.57 |
| Impact cost | 0.05 |
| Quantity Traded | 1,496,370.00 |
| Deliverable Quantity | 786,183.00 |
| % of Quantity to Traded | 52.54 |
| Security VaR | 13.07 |
| Index VaR | N/A |
| VaR Margin | 13.07 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 16.57 |
| Face Value | 10 |
Key Price Statistics of Fortis Healthcare Limited
The 52-week high for Fortis Healthcare Limited was ₹744.50, recorded on 30-Dec-2024. On the other hand, the 52-week low stands at ₹391.35, with the lowest value recorded on 26-Mar-2024.
The upper band for trading is ₹731.80, and the lower band is ₹487.90. The price band is 20%.
The stock's daily volatility stands at 2.05, while the annualized volatility is 39.17. The tick size for trading is ₹0.05.
| Price Information | Details |
|---|---|
| 52 Week High (30-Dec-2024) | 744.50 |
| 52 Week Low (26-Mar-2024) | 391.35 |
| Upper Band | 731.80 |
| Lower Band | 487.90 |
| Price Band (%) | 20 |
| Daily Volatility | 2.05 |
| Annualised Volatility | 39.17 |
| Tick Size | 0.05 |
Key Securities Statistics of Fortis Healthcare Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 09-May-2007 |
| Adjusted P/E | 54.9 |
| Symbol P/E | 56.61 |
| Index | NIFTY 500 |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Basic Industry | Hospital |
Security Status of Fortis Healthcare Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Fortis Healthcare Limited
| Subject | Date |
|---|---|
| Shareholders meeting | 20-Mar-2025 |
| Updates | 20-Mar-2025 |
| Copy of Newspaper Publication | 19-Feb-2025 |
| Notice Of Shareholders Meetings-XBRL | 19-Feb-2025 |
| Shareholders meeting | 18-Feb-2025 |
| Acquisition-XBRL | 15-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 14-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 14-Feb-2025 |
Corporate Actions of Fortis Healthcare Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 10 | Dividend - Re 1 Per Share | 24-Jul-2024 |
| 10 | Dividend - Re 1 Per Share | 20-Jul-2023 |
| 10 | Annual General Meeting | 16-Sep-2016 |
| 10 | Annual General Meeting | 14-Sep-2015 |
| 10 | Annual General Meeting | 18-Sep-2014 |
| 10 | Annual General Meeting | 19-Sep-2013 |
| 10 | Annual General Meeting | 21-Sep-2012 |
| 10 | Annual General Meeting | 12-Sep-2011 |
| 10 | Annual General Meeting | 13-Sep-2010 |
| 10 | Annual General Meeting | 22-Sep-2009 |
| 10 | Rhts Eq 2:5 & 2 Wrnt:2 Eq | 18-Aug-2009 |
| 10 | Annual General Meeting | 10-Sep-2008 |
| 10 | Agm | 19-Sep-2007 |
Board Meetings of Fortis Healthcare Limited
Financial Results of Fortis Healthcare Limited
Company Directory of Fortis Healthcare Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| N/A | Head Office/ Corporate Office | Unitech Business Park, Tower A Block- F, South City- I Sector 41 Gurgaon | GURGAON |
| N/A | Registered Office | Fortis Hospital Sector 62, Phase VIII Mohali | MOHALI |
| N/A | Transfer Agent | Kary Computershare Private Limited Plot No. 17 to 24 Vithalrao Nagar, Madhapur Hyderabad | HYDERABAD |
Insider Trading of Fortis Healthcare Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | ASHISH BHATIA | 5471985 | Sell |
| 7(2) | ASHISH BHATIA | 831729 | Sell |
| 7(2) | ASHISH BHATIA | 50199760 | Sell |
| 7(2) | Harinder Singh Chehal | 9100000 | Buy |
| 7(2) | ASHISH BHATIA | 29300000 | Buy |
| 7(2) | Anurag Kalra | 5005000 | Buy |
| 7(2) | MALAV HOLDINGS PVT LIMITED | 31983637.50 | Sell |
| 7(2) | MALVINDER MOHAN SINGH | 1528837.80 | Sell |
| 7(2) | SHIVINDER MOHAN SINGH | 1528837.80 | Sell |
| 7(2) | RHC HOLDING PVT LIIMITED | 28994512.50 | Sell |
| 7(2) | FORTIS HEALTHCARE HOLDINGS PRIVATE LIMITED | 11900000 | Pledge Invoke |
| 7(2) | FORTIS HEALTHCARE HOLDINGS PRIVATE LIMITED | 9100000 | Pledge Invoke |
| 7(2) | FORTIS HEALTHCARE HOLDINGS PRIVATE LIMITED | 9500000 | Pledge Revoke |
| 7(2) | FORTIS HEALTHCARE HOLDINGS PRIVATE LIMITED | 1800000 | Pledge Revoke |
| 7(2) | FORTIS HEALTHCARE HOLDINGS PRIVATE LIMITED | 2600000 | Pledge Revoke |
| 7(2) | FORTIS HEALTHCARE HOLDINGS PRIVATE LIMITED | 724600000 | Pledge Invoke |
| 7(2) | FORTIS HEALTHCARE HOLDINGS PRIVATE LIMITED | 1096400000 | Pledge Invoke |
| 7(2) | FORTIS HEALTHCARE HOLDINGS PRIVATE LIMITED | 2181400000 | Pledge Invoke |
| 7(2) | FORTIS HEALTHCARE HOLDINGS PRIVATE LIMITED | 2127200000 | Pledge Invoke |
| 7(2) | FORTIS HEALTHCARE HOLDINGS PRIVATE LIMITED | 2617500000 | Pledge Invoke |
Annual Reports of Fortis Healthcare Limited
Investor Complaints of Fortis Healthcare Limited
Event Calendar of Fortis Healthcare Limited
| Purpose | Details |
|---|---|
| Raising of Funds | To consider, inter-alia, to raise funds through issue of securities, aggregating upto Rs.1000 Crores. |
| Results | To inter alia, approve the Un-audited Financial Results of the Company, for the Quarter ended December 31, 2012. |
| Results | To inter alia, to approve the Audited Financial Results of the Company, for the financial year ended March 31, 2013. |
| Results | to inter alia, approve the Un-audited Financial Results of the Company for the Quarter ended June 30, 2013. |
| Results | Inter alia, to consider and approve the Un-audited Financial Results of the Company, for the Quarter ended September 30, 2013. |
| Results | inter alia, to consider and approve the Un-Audited Financial Results of the Company, for the Quarter ended December 31, 2013. |
| Results | To inter-alia consider annual financial results for the financial year ended March 31, 2014. |
| Results | To inter-alia, approve the Un-audited Financial Results of the Company, for the Quarter ended June 30, 2014. |
| Results | Inter alia, to consider and approve the Un-Audited Financial Results of the Company, for the Quarter ended September 30, 2014. |
| Results | Inter-alia, to consider and approve the Un-audited Financial Results of the Company, for the Quarter ended December 31, 2014. |
| Results | to inter-alia, approve the Audited Financial Results of the Company, for the Financial Year ended March 31, 2015. |
| Results | To inter-alia, approve the Un-Audited Financial Results of the Company, for the Quarter ended June 30, 2015. |
| Results | To inter-alia, approve the Un-Audited Financial Results of the Company, for the Quarter and half year ended September 30, 2015. |
| Results/Others | To inter-alia, approve the Un-Audited Financial Results of the Company, for the Quarter and nine months ended on December 31, 2015. |
| Results | To inter alia consider and approve the Audited Financial Statements for the quarter and year ended on March 31, 2016. |
| Results/Others | The Company had informed the Exchange that Board of Directors at its meeting scheduled to be held on August 04, 2016 inter-alia, consider and approve the Un-audited Financial Results for the quarter ended June 30, 2016. The Company has now informed the Exchange that the Board shall also be considering an enabling fund raising option including but not limited to qualified institutions placement (QIP), Foreign Currency Convertible Bond (FCCB), convertible securities or any other method and if approved to recommend the same to the shareholders for their approval at the ensuing annual general meeting of the Company. (revised) |
| Results | Inter alia, consider and approve the un-audited financial results for the quarter ended June 30, 2016. |
| Results | To , inter alia, consider and approve the Un-audited Financial Results for the quarter and half year ended September 30, 2016. |
| Results | to, inter-alia, consider and approve the Audited Financial Results for the quarter and financial year ended March 31, 2017. Further, the trading window of the Company for dealing in securities of the Company will remain closed from May 23, 2017 to June 1, 2017 (both days inclusive). |
| Results | To, inter-alia, consider and approve the Un-Audited Financial Results for the quarter ended June 30, 2017. |
| Results/Others | The Company had informed the Exchange regarding a meeting of the Board of Directors of the Company schedule to be held August 04, 2017, To, inter-alia, consider and approve the Un-Audited Financial Results for the quarter ended June 30, 2017. The Company has now informed the Exchange that the Board shall also be considering an enabling fund raising option including but not limited to qualified institutions placement (QIP), Foreign Currency Convertible Bond (FCCB), convertible securities or any other method and if approved to recommend the same to the shareholders for their approval at the ensuing annual general meeting of the Company. (Purpose Revised). |
| Results | To, inter-alia, consider and approve the Un-Audited Financial Results for the quarter and Half Year ended September 30, 2017. |
| Results | To, inter-alia, consider and approve the Un-Audited Financial Results for the quarter and Half Year ended September 30, 2017 and for the quarter and Period ended December 31, 2017. |
| Results | The Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held February 13, 2018, To, inter-alia, consider and approve the Un-Audited Financial Results for the quarter and Half Year ended September 30, 2017 and for the quarter and Period ended December 31, 2017. The Company has now informed the Exchange that the meeting of the Board of Directors has now been Scheduled to be held on February 28, 2018, for approval of the un-audited financial results for the Quarters ended September 30, 2017 and December 31, 2017. |
| Other business matters | To consider all options |
| Other business matters | inter-alia, consider and decide on various bids/proposals received by the company w.r.t. the ongoing fund raising, re-structuring, etc. and such related activities. |
| Financial Results | To, inter-alia, consider and approve the Audited Financial Results for the quarter and financial year ended March 31, 2018. |
| Financial Results | FORTIS : 11-Jun-2018 : The Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held on May 30, 2018, To, inter-alia, consider and approve the Audited Financial Results for the quarter and financial year ended March 31, 2018. The Company has now informed the Exchange that the meeting of the Board of Directors stands deferred to June 11, 2018. |
| Financial Results | FORTIS : 25-Jun-2018 : The Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held on June 11, 2018 To, inter-alia, consider and approve the Audited Financial Results for the quarter and financial year ended March 31, 2018. The Company has now informed the Exchange that the completion of the audit and accounts will require additional time to consider the aspects of the report comprehensively in the financial accounts. Accordingly, the Board at its meeting held June 11, 2018 decided to defer the approval of the quarterly and annual financial results for the period ended March 31, 2018. The date for the approval of the said accounts will be June 25,2018. |
| Fund Raising | To consider Fund Raising .Please note the requisite Notice was sent to the Stock Exchanges on July 10, 2018. However due to technical glitch. the same could not be uploaded necessary mail in this regard was sent on compliance@nse.co.in. |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2018 |
| Financial Results | To consider and approve the Un-Audited financial results for the quarter and period ended September 30, 2018. |
| Financial Results | Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Wednesday, February 13, 2019 to, inter-alia, consider and approve the Un-Audited Financial Results for the quarter and period endedDecember 31, 2018.Further, the trading window of the Company for dealing in securities of the Company will remain closed from February 6, 2019 to February 15, 2109 (both days inclusive).This is for your information and record please. |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2019 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2019 |
| Financial Results | Notice of Board Meeting under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to, inter-alia, consider and approve un-audited financial results for the quarter and period ended September 30, 2019 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2019Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting ofthe Board of Directors of the Company will be held on Friday, February 14, 2020 to, inter-alia consider and approve un-audited financial results for the quarter and period ended December 31, 2019.Further, in continuation to our letter ref. FHL/SEC/2019-20 dated December 31, 2019 captioned Closure of Trading Window , it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till February 16,2020.This is for your information and record please. |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2020 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2020 |
| Financial Results | Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Thursday, November 12, 2020 to, inter-alia, consider and approve un-audited financial results for the quarter and period ended September 30, 2020.Further, in continuation to our letter ref. FHL/SEC/2020-21 dated September 29, 2020 captioned Closure of Trading Window , it is hereby informed that the trading window of the Company fordealing in securities of the Company will remain closed till November 14, 2020.This is for your information and record please. |
| Financial Results | Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, February 5, 2021 to, inter-alia, consider and approve un-audited financial results for the quarter ended December 31, 2020.Further, in continuation to our letter ref. FHL/SEC/2020-21 dated December 30, 2020 captioned Closure of Trading Window , it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till February 7, 2021. |
| Financial Results | Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, August 13, 2021 to, inter-alia, consider and approve un-audited financial results for the quarter ended June 30, 2021.ￂﾠￂﾠFurther, in continuation to our letter ref. FHL/SEC/2021-22 dated June 29, 2021 captioned Closure of Trading Window , it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till August 15, 2021.ￂﾠￂﾠThis is for your information and record please.ￂﾠ |
| Financial Results | Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, November 12, 2021 to, inter-alia, consider and approve un-audited financial results for the quarter and period ended September 30, 2021.Further, in continuation to our letter ref. FHL/SEC/2021-22 dated September 29, 2021 captioned Closure of Trading Window , it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till November 14, 2021.This is for your information and record please. |
| Financial Results | Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, February 11, 2022 to, inter-alia, consider and approve un-audited financial results for the quarter and period ended December 31, 2021.Further, in continuation to our letter ref. FHL/SEC/2021-22 dated December 30, 2021 captioned Closure of Trading Window , it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till February 13, 2022.This is for your information and record please. |
| Financial results | Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Wednesday, May 25, 2022 to, inter-alia, consider and approve audited financial results for the quarter and year ended March 31, 2022.Further, in continuation to our letter ref. FHL/SEC/2021-22 dated March 30, 2022 captioned ￢ﾀﾜClosure of Trading Window￢ﾀﾝ, it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till May 27, 2022. |
| Financial results | Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, August 5, 2022 to, inter-alia, consider and approve un-audited financial results for the quarter ended June 30, 2022.Further, in continuation to our letter ref. FHL/SEC/2022-23 dated June 29, 2022 captioned ￢ﾀﾜClosure of Trading Window￢ﾀﾝ, it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till August 7, 2022.This is for your information and record. |
| Financial results | Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, November 11, 2022 to, inter-alia, consider and approve un-audited financial results for the quarter and period ended September 30, 2022.Further, in continuation to our letter ref. FHL/SEC/2022-23 dated September 29, 2022 captioned ￢ﾀﾜClosure of Trading Window￢ﾀﾝ, it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till November 13, 2022. |
| Financial Results | Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, February 10, 2023 to, inter-alia, consider and approve un-audited financial results for the quarter ended December 31, 2022.Further, in continuation to our letter ref. FHL/SEC/2022-23 dated December 29, 2022 captioned Closure of Trading Window , it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till February 12, 2023. |
| Financial Results/Dividend | Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Tuesday, May 23, 2023, inter-alia, to:a) consider and approve audited financial results of the Company for the quarter and financial year ended March 31, 2023; andb) consider and recommend final dividend, if any, on the equity shares of the Company for the financial year ended March 31, 2023. Further, in continuation to our letter ref. FHL/SEC/2022-23 dated March 30, 2023 captioned Closure of Trading Window , it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till May 25, 2023. |
| Financial Results | Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, August 4, 2023 to, inter-alia, consider and approve un-audited financial results for the quarter ended June 30, 2023.Further, in continuation to our letter ref. FHL/SEC/2023-24 dated June 29, 2023 captioned Closure of Trading Window , it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till August 6, 2023. |
| Financial Results | Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, November 10, 2023 to, inter-alia, consider and approve un-audited financial results for the quarter and period ended September 30, 2023.Further, in continuation to our letter ref. FHL/SEC/2023-24 dated September 29, 2023 captioned Closure of Trading Window , it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till November 12, 2023. |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2023 |
| Financial Results/Dividend | Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Thursday, May 23, 2024, inter-alia, to: a) consider and approve audited financial results of the Company for the quarter and financial year ended March 31, 2024; and b) consider and recommend final dividend, if any, on the equity shares of the Company for the financial year ended March 31, 2024. Further, in continuation to our letter ref. FHL/SEC/2023-24 dated March 27, 2024 captioned Closure of Trading Window , it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till May 25, 2024. |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
| Fund Raising | To consider Fund Raising |
| Fund Raising | To consider Fund Raising |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2024 |
Share Transfers of Fortis Healthcare Limited
Voting Results of Fortis Healthcare Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 20-MAR-2025 | Postal Ballot | Approval of appointment of Mr. Leo Puri (DIN:01764813) as Director (an Independent & Non-Executive Director) of the Company. |
| 20-MAR-2025 | Postal Ballot | To consider amendment in the Articles of Association of Agilus Diagnostics Limited |
| 20-MAR-2025 | Postal Ballot | To consider raising debt through Fortis Hospotel Limited (￢ﾀﾜFHTL￢ﾀﾝ), a wholly owned subsidiary of the Company for meeting funding requirements, largely to finance the acquisition of Shrimann Hospital and for its future growth/ capex requirements and to pledge, mortgage, hypothecate and/or create charge on any assets / properties of FHTL. |
| 20-MAR-2025 | Postal Ballot | Proposal for acquisition of Shrimann Hospital at Jalandhar City and transactions in relation thereto to be entered into by Fortis Hospotel Limited, Wholly Owned Subsidiary Company |
| 20-MAR-2025 | Postal Ballot | To consider Amendment in the Articles of Association of the Company. |
| 20-MAR-2025 | Postal Ballot | To Recommend Payment of Commission/Remuneration to Chairman (Independent Director) Till March 31, 2027 |
| 20-MAR-2025 | Postal Ballot | Approval of appointment of Mr. Leo Puri (DIN:01764813) as Director (an Independent & Non-Executive Director) of the Company. |
| 20-MAR-2025 | Postal Ballot | To consider amendment in the Articles of Association of Agilus Diagnostics Limited |
| 20-MAR-2025 | Postal Ballot | To consider raising debt through Fortis Hospotel Limited (￢ﾀﾜFHTL￢ﾀﾝ), a wholly owned subsidiary of the Company for meeting funding requirements, largely to finance the acquisition of Shrimann Hospital and for its future growth/ capex requirements and to pledge, mortgage, hypothecate and/or create charge on any assets / properties of FHTL. |
| 20-MAR-2025 | Postal Ballot | Proposal for acquisition of Shrimann Hospital at Jalandhar City and transactions in relation thereto to be entered into by Fortis Hospotel Limited, Wholly Owned Subsidiary Company |
| 20-MAR-2025 | Postal Ballot | To consider Amendment in the Articles of Association of the Company. |
| 20-MAR-2025 | Postal Ballot | To Recommend Payment of Commission/Remuneration to Chairman (Independent Director) Till March 31, 2027 |
| 03-OCT-2024 | Postal Ballot | To consider entering into a material related party transaction between the Company, NYLIM Jacob Ballas India Fund III LLC (￢ﾀﾜNJBIF￢ﾀﾝ) and Resurgence PE Investments Limited (formerly known as Avigo PE Investments Limited) (￢ﾀﾜResurgence￢ﾀﾝ) (NJBIF and Resurgence are collectively, ￢ﾀﾜRelated Parties￢ﾀﾝ) as part of a composite transaction whereby the Company shall acquire the entire stake held by NJBIF, Resurgence and International Finance Corporation (￢ﾀﾜIFC￢ﾀﾝ) (collectively, ￢ﾀﾜPE Investors￢ﾀﾝ) in Agilus Diagnostics Limited (￢ﾀﾜADL￢ﾀﾝ) (representing 31.52% equity stake of paid up share capital of ADL). |
| 03-OCT-2024 | Postal Ballot | To consider Amendment in the Articles of Association of the Company |
| 03-OCT-2024 | Postal Ballot | To consider creation of encumbrance on the securities held by the Company in Agilus Diagnostics Limited (￢ﾀﾜADL￢ﾀﾝ) for the purposes of raising funds by way of issuance of the Non-Convertible Debentures. |
| 03-OCT-2024 | Postal Ballot | To consider raising debt through issuance of listed, senior, secured, rated Non-Convertible Debentures by the Company and utilization thereof for the purposes of the proposed acquisition by the Company of 31.52% shareholding of Agilus Diagnostics Limited held by NYLIM Jacob Ballas India Fund III LLC, Resurgence PE Investments Limited (formerly known as Avigo PE Investments Limited) and International Finance Corporation. |
| 02-AUG-2024 | AGM | To consider and adopt the Audited Standalone Financial Statements of the Company together with Reports of the Board and Auditorsￂ thereon and the Audited Consolidated Financial Statements of the Company including Auditorsￂ Report thereon for the financial year ended on March 31, 2024. |
| 02-AUG-2024 | AGM | To appoint Mr Mehmet Ali Aydinlar (DIN- 10073483), who retires by rotation and being eligible, offers himself for re- appointment as a Director. |
| 02-AUG-2024 | AGM | To appoint Mr Dilip Kadambi (DIN-02148022), who retires by rotation and being eligible, offers himself for re-appointment as a Director. |
| 02-AUG-2024 | AGM | To declare dividend of Rs. 1/- (Rupee One) per equity share, for the financial year ended March 31, 2024. |
FAQs on Fortis Healthcare Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.